Dantrium® IV, Dantrolene Sodium, Intravenous Injection, 20 mg/ml Strength, 70ml, 6/Pkg, NDC 42023-0123-06 - McKesson Medical-Surgical, Inc.

Dantrium® IV is a malignant hyperthermia treatment agent. It is a sterile, non-pyrogenic, lyophilized formulation of dantrolene sodium for injection. Dantrium Intravenous is supplied in 70 mL vials containing 20 mg dantrolene sodium, 3000 mg mannitol, and sufficient sodium hydroxide to yield a pH of approximately 9.5 when reconstituted with 60 mL sterile water for injection USP (without a bacteriostatic agent).
The item(s) denoted below (*) cannot be added to your cart. For more information, click HERE Please unselect this item(s) to proceed to your cart.
Auto Free Good
Advantage Promotion
My Catalog
My Catalog (Rep)
On Formulary
Hazmat-No Charge
Additional Information
Schedule 2 and 2N
Schedule 3, 3N, 4 and 5
List 1
Prices in Green indicate discounted price.